ARTICLE | Clinical News
Direct-acting antivirals regulatory update
December 15, 2016 11:15 PM UTC
EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) completed a safety review confirming that patients treated with direct-acting antivirals (DAAs) to treat HCV infection may be at risk for HBV r...